Category | Insight journal – Dealtalk

Equity firms eye Bayer’s plastic business merger

Posted on 27 October 2014

Private equity firms are circling Bayer’s €10bn plastics business merger, hoping to divert the German drugmaker from its plan to list the division, two people familiar with the matter said yesterday.

Tags: , ,

Both, Actavis and Sanofi competing for Omega Pharma

Posted on 22 October 2014

Several companies are rumored to be competing to acquire Omega Pharma, the fastest growing consumer healthcare company in the U.K. and Ireland.

Tags: ,

AbbVie rethinking the $54 billion acquisition of Shire

Posted on 16 October 2014

In response to recent changes to the U.S. tax code to discourage so-called tax inversion deals, Chicago-based AbbVie recently indicated it was rethinking its $54 billion takeover bid of U.K.-based Shire.

Tags: , ,

Actavis chasing Allergan also…which way will Allergan go?

Posted on 15 October 2014

Actavis Plc plans to approach Allergan Inc again about a potential merger, as the Botox maker warms up to the possibility of a sale, people familiar with the matter said on Tuesday.

Arbor Pharma looking for an acquisition and merger partner

Posted on 06 October 2014

Arbor Pharmaceuticals LLC is allegedly exploring a potential acquisition and merger partner that could bring in more than $1 billion, according to people who are close to the situation.

Tags: , , ,

Pfizer is in talks to acquire Actavis

Posted on 24 September 2014

Pfizer Inc. has approached Actavis with a possibility to acquire the company.

Tags: , ,

Akorn to bid for an acquisition of UCB’s subsidiary

Posted on 15 September 2014

Akorn targets UCB‘s subsidiary for acquisition for tax inversion. 

Tags: , ,

Omega Pharma rumored to be sought after by big pharma companies

Posted on 01 September 2014

Belgium-based healthcare company Omega Pharma NV is allegedly attracting numerous bids from businesses across the big pharma companies, according to Bloomberg Businessweek. Perrigo and Boehringer Ingelheim GmbH are rumored to be interested in acquiring the company. 

Tags: , , , , ,

AstraZeneca and Pfizer in the news for another possible m&a bid

Posted on 01 September 2014

AstraZeneca stock rose two percent to £45.67 pounds yesterday after the Swedish newspaper Dagens Industry suggested another possible Pfizer m&a  bid. AstraZeneca stocks have risen 9.5% in the last week, following a stream of good news regarding its pipeline and takeover bids by Pfizer.

Tags: , , ,

M&A rumors for buyout of Achillion Pharmaceuticals by big pharma

Posted on 28 August 2014

UBS analyst Andrew Peters suggested that a recent takeover big in the biotech space of California-based InterMune, Inc.  by Roche was the harbinger of more M&A rumors to come.

Tags: , , ,

RSS Feed Linked In Twitter

Latest Tweets